Related Experiment Video
Updated: Jul 19, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Atrioventricular junction ablation followed by resynchronization therapy in patients with congestive heart failure
Mohamed H Hamdan1, Roger A Freedman, Edward M Gilbert
1Department of Internal Medicine, Division of Cardiology, University of Utah Health Sciences Center, Salt Lake City, Utah 84132-2401, USA. mohamed.hamdan@hsc.utah.edu
Insights
Atrial fibrillation (AF) and heart failure (CHF) impact millions. Biventricular pacing after AV junction ablation may improve exercise capacity in CHF patients with AF, unlike RV pacing.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Atrial fibrillation (AF) and congestive heart failure (CHF) are prevalent cardiovascular conditions.
- Irregular ventricular response in AF may contribute to left ventricular dysfunction.
- Previous studies comparing pharmacologic rate control to AV junction ablation with RV pacing showed no improvement.
Purpose of the Study:
- To test if AV junction ablation followed by biventricular pacing improves exercise capacity and functional status in CHF patients with AF.
- To compare biventricular pacing against pharmacologic rate control.
- To evaluate outcomes regardless of rate or QRS duration in patients with chronic AF and reduced ejection fraction.
Main Methods:
- A prospective, randomized, double-blinded, multicenter trial (AVERT-AF).
- Enrollment of 180 patients with chronic AF and depressed ejection fraction.
- Primary endpoint: exercise duration.
Main Results:
- The study hypothesizes that AVJ ablation with biventricular pacing significantly improves exercise capacity.
- This approach aims to overcome the limitations of RV apical pacing after AVJ ablation.
- Results are expected to guide treatment for AF in patients with left ventricular dysfunction.
Conclusions:
- The AVERT-AF trial will provide crucial data on optimal management strategies.
- Findings will help define the best treatment for this common arrhythmia in patients with left ventricular dysfunction.
- This research addresses a significant unmet need in cardiovascular medicine.
Abstract:
Atrial fibrillation (AF) and congestive heart failure (CHF) affect millions of patients in the United States. Several studies suggest that AF and in particular the irregular ventricular response might be contributing to the left ventricular dysfunction. Studies that compared pharmacologic rate control to atrioventricular junction (AVJ) ablation followed by right ventricular pacing which restores a regular ventricular response, failed to show an improvement when compared to pharmacological rare control. These results might be explained by the fact that while AVJ ablation restored a regular ventricular response, it subjected patients to the detrimental effects of RV apical pacing. The AVERT-AF trial (Atrio-VEntricular Junction Ablation Followed by Resynchronization Therapy in patients with CHF and AF) is a prospective, randomized, double-blinded, multicenter trial that will be testing the hypothesis that AVJ ablation followed by biventricular pacing significantly improves exercise capacity and functional status compared to pharmacologic rate control in patients with chronic AF and depressed ejection fraction, regardless of rate or QRS duration. A total of 180 patients will be enrolled to test the primary endpoint, which is exercise duration. Patients_enrollment will begin in summer 2006 and is expected to be completed in 2008. The results of this trial should help define the best treatment option for this common arrhythmia in patients with left ventricular dysfunction.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias VI: Management of Dysrhythmias
Heart Failure VI: Adjunct Therapies
Cardiopulmonary Resuscitation III: AED Use

